On 3‐MMC: A Cathinone I Have Come to Know and Love
ABSTRACT This article attempts to complicate the mythology of a compound in a state of becoming. I will trace lightly its origins as a cultural disruptor and how I am implicated in this imperative. Introducing you to 3‐MMC will require multiple modes of storytelling and taking of liberties, drawing on literature reviews, practice‐based research, prose,
Carmen Ostrander
wiley +1 more source
Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days. [PDF]
Pipitone RN +8 more
europepmc +1 more source
Problems in comparing tobacco regulatory models and excise when only two countries are considered
Addiction, EarlyView.
Simon Chapman, Sam Egger, Becky Freeman
wiley +1 more source
Sudden Unexpected Death in Infancy in New Zealand: A Review of Coronial Recommendations
ABSTRACT Aims Sudden Unexpected Death in Infancy (SUDI) remains a leading cause of post‐neonatal mortality in Aotearoa New Zealand. We analysed New Zealand coronial findings and recommendations to identify recurring modifiable risks, social determinants of health, and system‐level failures that might inform prevention strategies.
Edwin A. Mitchell +2 more
wiley +1 more source
Abstract Background Attention‐deficit/hyperactivity disorder (ADHD) is highly prevalent in adults with anxiety and related disorders (ARDs). Quantitative research on this clinical population is mixed, with some studies suggesting that anxiety is protective against some symptoms of ADHD and others in which co‐occurring ARDs and ADHD are linked to poorer
Arij Alarachi +3 more
wiley +1 more source
UK Medical Cannabis Registry: An Analysis of Outcomes of Medical Cannabis Therapy for Hypermobility-Associated Chronic Pain. [PDF]
Dickinson M +9 more
europepmc +1 more source
Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli +7 more
wiley +1 more source
UK Medical Cannabis Registry: A clinical outcomes analysis for insomnia. [PDF]
Aggarwal A +10 more
europepmc +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data. [PDF]
Weaver R +3 more
europepmc +1 more source

